Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Healthcare | 17.49% |
| 3 | Consumer Discretionary | 17.05% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARYAU
451
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $8.49M | 0.01% |
+829,513
| New | +$8.54M |
|
|
CWEN.A
452
DELISTED
Clearway Energy Class A
CWEN.A
| $8.44M | 0.01% |
498,852
+517
| +0.1% | +$9.55K |
|
453
Box
BOX
$4.35B
| $8.4M | 0.01% |
497,912
-36,475
| -7% | -$671K |
|
|
AXE
454
DELISTED
Anixter International Inc
AXE
| $8.11M | 0.01% |
149,227
-114,270
| -43% | -$7.19M |
|
|
APLS
455
DELISTED
Apellis Pharmaceuticals
APLS
| $7.74M | 0.01% |
586,924
+12,065
| +2% | +$185K |
|
|
RUBY
456
DELISTED
Rubius Therapeutics, Inc
RUBY
| $7.68M | 0.01% |
477,596
+5,387
| +1% | +$98.2K |
|
|
TVTY
457
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.68M | 0.01% |
309,497
-408,874
| -57% | -$13.6M |
|
458
Kosmos Energy
KOS
$1.57B
| $7.57M | 0.01% |
1,859,873
+492,290
| +36% | +$3.04M |
|
|
WES
459
DELISTED
Western Gas Partners Lp
WES
| $7.57M | 0.01% |
+179,233
| New | +$7.97M |
|
|
ANDX
460
DELISTED
Andeavor Logistics LP
ANDX
| $7.54M | 0.01% |
231,995
-10,871
| -4% | -$432K |
|
461
Wheaton Precious Metals
WPM
$49.9B
| $7.46M | 0.01% |
382,016
-65,847
| -15% | -$1.12M |
|
462
Chemours
CC
$2.5B
| $7.22M | 0.01% |
256,031
-36,912
| -13% | -$1.17M |
|
|
NBLX
463
DELISTED
Noble Midstream Partners LP
NBLX
| $7.19M | 0.01% |
249,218
-11,677
| -4% | -$413K |
|
464
Alcoa
AA
$12B
| $6.61M | 0.01% |
248,786
-51,978
| -17% | -$1.75M |
|
|
CEQP
465
DELISTED
Crestwood Equity Partners LP
CEQP
| $6.58M | 0.01% |
235,714
-11,043
| -4% | -$362K |
|
466
Insulet
PODD
$11.5B
| $6.57M | 0.01% |
82,820
+79,234
| +2,210% | +$6.71M |
|
467
Ocular Therapeutix
OCUL
$1.81B
| $6.5M | 0.01% |
1,632,646
-703,343
| -30% | -$3.88M |
|
|
WBT
468
DELISTED
Welbilt, Inc.
WBT
| $6.5M | 0.01% |
584,786
+4,908
| +0.8% | +$75.7K |
|
469
Hudbay
HBM
$10.1B
| $6.48M | 0.01% |
1,368,195
-97,259
| -7% | -$457K |
|
470
Constellium
CSTM
$3.77B
| $6.38M | 0.01% |
913,318
-116,682
| -11% | -$1.04M |
|
471
Warrior Met Coal
HCC
$4.2B
| $6.29M | 0.01% |
260,759
-17,092
| -6% | -$437K |
|
472
AnaptysBio
ANAB
$1.57B
| $6.15M | 0.01% |
96,400
-2,193
| -2% | -$163K |
|
|
SEI
473
Solaris Energy Infrastructure
SEI
$3.18B
| $5.99M | 0.01% |
495,223
-33,522
| -6% | -$476K |
|
474
Heron Therapeutics
HRTX
$93.8M
| $5.96M | 0.01% |
229,626
+2,575
| +1% | +$70.8K |
|
475
Kodiak Sciences
KOD
$2.59B
| $5.66M | 0.01% |
+797,423
| New | +$7.06M |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.